Fig. 1 · Structure
Documents & Downloads
Timdarpacept
SIRPa Fusion Protein
Timdarpacept is a recombinant SIRPa-Fc fusion protein designed to activate macrophages by blocking the CD47-SIRPa interaction. This mechanism enhances anti-tumor activity, making it a valuable tool in cancer research. Its application includes studying immune modulation and developing therapeutic strategies aimed at improving anti-cancer immunity.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2749520-17-8 |
| Applications | SIRPa Fusion Protein |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.